X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-cytokinetics-heart-drug-2023-02-28/
https://www.reuters.com/business/healthcare-pharmaceuticals/cytokinetics-heart-drug-fails-secure-fda-panels-support-2022-12-13/
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-staff-reviewers-flag-safety-concerns-over-cytokinetics-heart-drug-2022-12-09/
https://www.globenewswire.com/news-release/2022/12/09/2571098/35409/en/Cytokinetics-Announces-Availability-of-Briefing-Documents-for-FDA-Advisory-Committee-Meeting-on-Omecamtiv-Mecarbil.html
https://www.globenewswire.com/news-release/2022/06/24/2468701/35409/en/Cytokinetics-Announces-Date-for-FDA-Advisory-Committee-Meeting-to-Review-New-Drug-Application-for-Omecamtiv-Mecarbil.html
https://www.globenewswire.com/news-release/2022/05/17/2444826/35409/en/Cytokinetics-Provides-Regulatory-Update-Related-to-New-Drug-Application-for-Omecamtiv-Mecarbil.html
https://www.fiercebiotech.com/biotech/cytokinetics-heart-failure-drug-slated-nov-30-fda-decision-fails-improve-exercise-capacity
https://www.globenewswire.com/news-release/2022/02/04/2379227/35409/en/Cytokinetics-Announces-FDA-Acceptance-of-New-Drug-Application-for-Omecamtiv-Mecarbil-for-the-Treatment-of-Heart-Failure-With-Reduced-Ejection-Fraction.html
https://endpts.com/cytokinetics-gets-the-royalty-treatment-snagging-up-to-450m-to-support-closely-watched-heart-programs/
https://www.globenewswire.com/news-release/2021/12/20/2355153/35409/en/Cytokinetics-and-JI-XING-Announce-Expansion-of-Collaboration-to-Include-Licensing-of-Omecamtiv-Mecarbil-in-China-RTW-to-Add-to-Its-Investment-in-Cytokinetics.html
https://www.globenewswire.com/news-release/2021/09/12/2295408/35409/en/Cytokinetics-Announces-Results-From-REDWOOD-HCM-and-GALACTIC-HF-Presented-in-Late-Breaking-Clinical-Trial-Session-at-the-HFSA-Annual-Scientific-Meeting.html
https://www.globenewswire.com/news-release/2021/08/31/2289106/35409/en/Cytokinetics-Announces-Results-From-REDWOOD-HCM-and-GALACTIC-HF-to-Be-Presented-in-Late-Breaking-Clinical-Trials-Session-at-the-HFSA-Annual-Scientific-Meeting.html
https://www.globenewswire.com/news-release/2021/06/15/2247169/35409/en/Cytokinetics-Announces-Completion-of-Enrollment-in-METEORIC-HF-The-Second-Phase-3-Clinical-Trial-of-Omecamtiv-Mecarbil-in-Patients-With-Heart-Failure-With-Reduced-Ejection-Fraction.html
https://www.fiercebiotech.com/biotech/amgen-kicks-heart-failure-med-back-to-cytokinetics-after-galactic-flop
http://investors.amgen.com/news-releases/news-release-details/fda-grants-fast-track-designation-omecamtiv-mecarbil-heart/
https://www.prnewswire.com/news-releases/oramed-reports-positive-results-in-the-final-cohort-of-its-phase-2b-oral-insulin-trial-301011661.html
http://ir.cytokinetics.com/news-releases/news-release-details/cytokinetics-announces-publication-relating-design-galactic-hf
https://www.fiercebiotech.com/biotech/aha-analysis-counters-concerns-about-amgen-heart-failure-drug
http://www.pharmatimes.com/news/mhra_issues_drug_safety_warning_for_neo-mercazole_in_pregnancy_1279014
http://www.pmlive.com/pharma_news/amgen,_servier_start_second_phase_3_trial_of_heart_failure_hope_1279105
https://www.nasdaq.com/article/amgen-starts-phase-iii-enrollment-for-heart-failure-drug-cm1104964
Market Place
Share 
